Granules India (BOM:532482) 3-Year EBITDA Growth Rate : 0.50% (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Granules India 3-Year EBITDA Growth Rate?

Granules India's EBITDA per Share for the three months ended in Mar. 2024 was ₹10.60.

During the past 12 months, Granules India's average EBITDA Per Share Growth Rate was -5.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 0.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 14.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 17.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Granules India was 48.50% per year. The lowest was 0.50% per year. And the median was 18.25% per year.

Competitive Comparison of Granules India's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Granules India's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Granules India's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Granules India's 3-Year EBITDA Growth Rate falls into.

Granules India 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Granules India (BOM:532482) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Granules India 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Granules India's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Granules India (BOM:532482) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Granules India Ltd (BOM:532482) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

GRANULES:India

Address

3rd Block, My Home Hub, 2nd Floor, Madhapur, Hyderabad, TG, IND, 500 081

Website

https://www.granulesindia.com

Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.

Granules India (BOM:532482) Headlines

No Headlines